Fernand Labrie

Participation at SYMPOSIA

Page 8 of 11, showing 50 records out of 506 total, starting on record 351, ending on 400

Year(s) Title
1988 Annual Meeting of the Colegio Mexicano de Urologia, "Endocrine Therapy of Prostate Cancer", Guanajuato, Mexico (March 1988)
2000 Annual Meeting of the Canadian Society of Endocrinology and Metabolism, Androgens and Antiandrogens in Clinical Endocrinology, “Inhibitors of Androgen Formation and Action in Prostatic Diseases”, Hali
1981 Annual Meeting of the American Association for the Advancement of Science (AAAS), Symposium on Reproductive Biology and its Impact on Population, "Control of Gonadotropin Secretion", Toronto (January
2001 Annual Female Sexual Function Forum: Androgen Deficiency Syndrome in Women: Implications and Mechanisms and Treatments, “Role of Androgens and their Precursor DHEA in Women”, Boston (October 2001)
2001 Annual Female Sexual Function Forum – Plenary and State-of-the-Art Lecture, “Role of Steroid Hormones as they Pertain to Female Sexual Functions”, Boston (October 2001)
1998 Annual Congress of the Société argentine de recherches cliniques, "Molecular Biology of Steroidogenesis in the Prostate and Mammary Gland", Mar del Lata, Argentina (November 1998)
1998 Annual Congress of the Société argentine de recherches cliniques, "Crucial Role of Endocrine Therapy at all Stages of Prostate Cancer", Mar del Plata, Argentina (November 1998)
1983 Annual Congress of the Association of Urologists of Québec, "Suppression totale des androgènes dans le cancer de la prostate", Montreal (November 1983)
1978 Annual Congress of l'ACFAS, "Récents développements en neuroendocrinologie", Ottawa (May 1978)
2006 Androgen Excess Society – 4th Annual Meeting “Role of the adrenal in androgen excess in women”, Boston, June 2006.
2000 American Chemical Society Meeting, Symposium on Selective Estrogen Receptor Modulators, "EM-652 (SCH-57068): First Pure Response-Specific ER Regulator (Pure SERR) having Activities Ranging from Pure A
1984 American Cancer Society Science Writers' Seminar, "New Treatment Based on Complete Androgen Blockade Causes a Dramatic Response in Prostate Cancer", Daytona Beach (April 1984)
1992 American Cancer Society National Conference on Prostate Cancer, "Total Androgen Blockade", San Diego (February 1992)
1996 Advances in the Management of Locally Advanced Prostate Cancer; Optimal Use of Hormonal Manipulation and Radiotherapy, « Clinical Implication of Recent Randomized Trials Comparing Radiotherapy alone,
1996 Advances in the Management of Locally Advanced Prostate Cancer; Optimal Use of Hormonal Manipulation and Radiotherapy, "Combined Androgen Blockade: Mechanisms and Critical Role in Prostate Cancer Ther
1986 Advances in the Hormonal Treatment of Prostate Cancer, "Combination therapy with a Pure Antiandrogen and Castration in Advanced Prostate Cancer", Barcelona (October 1986)
1982 Actualités pharmacologiques, "Effets inhibiteurs de la LHRH sur les fonctions gonadiques", Montpellier (November 1982)
2001 9th World Congress of Gynecological Endocrinology, “SERMs – From Pure Estrogen Antagonists to Complete Agonists”, Hong Kong (December 2001)
1999 9th International World Congress on the Menopause, International Menopause Society, "Mechanisms of Sex Steroid Formation and Action", Yokohama, Japan (October 1999)
1989 9th International Symposium of the Journal of Steroid Biochemistry, "Cloning and Sequence Analysis of 17ß Estradiol Dehydrogenase from Human Placenta, Testis and Mammary Carcinoma ZR-75-1", Las Palmas
1996 9th European Testis Workshop on Molecular and Cellular Endocrinology, "The 3?-HSD Gene Family: Lessons from Type II 3?-HSD Congenital Deficiency", Geilo, Norway (April 1996)
1989 9th Annual Cancer Symposium Continuum of Care in the Treatment of Cancer, "The Management of Metastatic Prostatic Carcinoma", Warren, Ohio (March 1989)
2008 96th Annual Meeting of the Japan Urological Association, “Dream of antiandrogens therapy for prostate cancer”, Yokohama, April 2008
2003 93th Annual Meeting of the American Urological Association, Takeda Evening Seminar on “Future Prospects for Primary Hormone Therapy in Localized and Locally Advanced Prostate Cancer”, The very high ef
2000 8th World Congress of Gynecological Endocrinology, « DHEA Replacement Therapy as Source of Androgens and Estrogens at Menopause » Florence (December 2000)
1987 8th International Symposium of the Journal of Steroid Biochemistry, "The Role of Adrenal Sex Steroids in Cancer", Paris (May 1987)
1998 8th International Prostate Cancer Update, "Steroid Metabolism in the Prostate", Beaver Creek, Colorado (January 1998)
1998 8th International Prostate Cancer Update, "Optimal Duration of Neoadjuvant and Adjuvant Androgen Blockade", Beaver Creek, Colorado (January 1998)
1998 8th International Prostate Cancer Update, "Canadian Trial Screening Results", Beaver Creek, Colorado (January 1998)
1998 8th International Prostate Cancer Update, "Adjuvant Endocrine Therapy with Radiation or Surgery", Beaver Creek, Colorado (January 1998)
1984 8th Annual Seminar of the Canadian Committee for Fertility Research, "LHRH Analogues and Fertility Control", Calgary (September 1984)
2000 82nd Annual Meeting of the US Endocrine Society, CMES Ancillary Symposium “Beyond Receptors : The Emerging Role of Enzyme Modulators”, « The Intracrine Concept and Tissue-Specific Response », “Intracr
1999 7th World Congress of Gynecological Endocrinology "Genomic and Non-Genomic Steroid Hormone Effects", "Potential of DHEA as Hormone Replacement Therapy at Menopause", Buenos Aires (April 1999)
1999 7th World Congress of Gynecological Endocrinology "Endocrine Aspects Involving the Hypothalamo-Pituitary Adrenal Axis", "Intracrinology: its Role in Human Disease", Buenos Aires (April 1999)
1978 7th International Symposium on Parkinson's Disease, Québec City (September 1978)
2003 7th International Symposium on GnRH Analogues in Cancer and Human Reproduction, “Androgen Blockage in Prostate Cancer – Possibility of Cure in Localized Disease”, Amsterdam (February 2003)
1997 7th International Prostate Cancer Update, Progress and Prospects for Chemoprevention of Prostate Cancer, « Steroid Metabolism in the Prostate : Relevance to Antiandrogenic Chemopreventive Agents », Be
1994 7th International Congress on Obesity, “Cancer - What are the Roles and Sources of Hormones on Obesity?”, Toronto (August 1994)
1986 7th International Congress on Hormonal Steroids, Symposium on Steroids and Prostatic Cancer, "Four-Year Clinical Experience with the Combined Use of an LHRH Agonist and Flutamide in the Treatment of A
1978 7th International Congress of Pharmacology, "Hormone Receptors as Primary Sites of Control of Cellular Activity", Paris (July 1978)
1984 7th International Congress of Endocrinology, "Dramatic Response to a New Antihormonal Treatment for Prostate Cancer", Québec City (July 1984)
2005 7th European Congress of Endocrinology – HRT-clinical management « SERMs and future perspectives », Göteborg, September 2005.
1986 7th Congress of European Association of Urology, Symposium on Advances in Treatment of Prostatic Cancer: Focus on Flutamide - a New Antiandrogen", "Treatment with Flutamide in Association with an LHRH
1996 7th Annual Urology Update, « Blockade, its Essential Role at all Stages of Prostate Cancer Therapy », Philadelphia, PA (October 1996)
1993 7th Annual Symposium on the Long-Term Effects of Estrogen Deprivation, “Progestins and Breast Cancer”, Victoria, B.C. (July 1993)
1992 74th Annual Meeting of the US Endocrine Society, Symposium on Steroid Antagonists, "The Use of Antiandrogens in Prostate Cancer", San Antonio (June 1992)
1987 70th Canadian Chemical Conference, New Developments in the Field of Antisteroids, "Antiandrogens in the Therapy of Prostate Cancer", Québec City (June 1987)
1973 6th Karolinska Symposium on Research Methods in Reproductive Endo-crinology, Geneva (May 1973)
2001 6th International Symposium on GnRH Analogues in Cancer and Human Reproduction, “Key Role of GnRH Agonists in the First Pivotal Studies Shown to Improve Survival in Localized Prostate Cancer”, Geneva
2001 6th International Symposium on GnRH Analogues in Cancer and Human Reproduction, “A Strong Candidate Prostate Cancer Predisposition Gene at Chromosome 17p”, Geneva (February 2001)
<< previous | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards